Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
28 05 2019
Historique:
received: 12 12 2018
accepted: 25 05 2019
pubmed: 29 5 2019
medline: 26 2 2020
entrez: 29 5 2019
Statut: epublish

Résumé

Coordination of the cellular response to DNA damage is organised by multi-domain 'scaffold' proteins, including 53BP1 and TOPBP1, which recognise post-translational modifications such as phosphorylation, methylation and ubiquitylation on other proteins, and are themselves carriers of such regulatory signals. Here we show that the DNA damage checkpoint regulating S-phase entry is controlled by a phosphorylation-dependent interaction of 53BP1 and TOPBP1. BRCT domains of TOPBP1 selectively bind conserved phosphorylation sites in the N-terminus of 53BP1. Mutation of these sites does not affect formation of 53BP1 or ATM foci following DNA damage, but abolishes recruitment of TOPBP1, ATR and CHK1 to 53BP1 damage foci, abrogating cell cycle arrest and permitting progression into S-phase. TOPBP1 interaction with 53BP1 is structurally complimentary to its interaction with RAD9-RAD1-HUS1, allowing these damage recognition factors to bind simultaneously to the same TOPBP1 molecule and cooperate in ATR activation in the G1 DNA damage checkpoint.

Identifiants

pubmed: 31135337
doi: 10.7554/eLife.44353
pii: 44353
pmc: PMC6561707
doi:
pii:

Substances chimiques

Carrier Proteins 0
DNA-Binding Proteins 0
Multiprotein Complexes 0
Nuclear Proteins 0
TOPBP1 protein, human 0
TP53BP1 protein, human 0
Tumor Suppressor p53-Binding Protein 1 0
ATR protein, human EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1
CHEK1 protein, human EC 2.7.11.1
Checkpoint Kinase 1 EC 2.7.11.1

Banques de données

PDB
['6RMM']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C302/A14532
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C302/A24386
Pays : United Kingdom

Informations de copyright

© 2019, Bigot et al.

Déclaration de conflit d'intérêts

NB, MD, RB, FW, AO, LP No competing interests declared

Références

Cell Cycle. 2011 Feb 15;10(4):671-9
pubmed: 21301228
DNA Repair (Amst). 2014 Oct;22:165-74
pubmed: 25087188
Bioinformatics. 2009 Jun 1;25(11):1463-5
pubmed: 19346324
Curr Biol. 2011 Jul 12;21(13):1152-7
pubmed: 21700459
Subcell Biochem. 2010;50:119-41
pubmed: 20012580
Genes Dev. 2000 Feb 1;14(3):289-300
pubmed: 10673501
Cell. 2010 Feb 5;140(3):349-59
pubmed: 20116089
Oncogene. 2006 Jun 29;25(28):3894-904
pubmed: 16474843
Genes Dev. 2008 Aug 1;22(15):2034-47
pubmed: 18676809
Mol Cell. 2016 Oct 6;64(1):51-64
pubmed: 27546791
Nature. 2013 Jul 4;499(7456):50-4
pubmed: 23760478
Oncogene. 2016 Apr 14;35(15):2003-10
pubmed: 26165835
Sci Rep. 2017 Sep 14;7(1):11650
pubmed: 28912563
Cell Rep. 2014 Sep 11;8(5):1583-94
pubmed: 25159151
Cell. 2006 Dec 29;127(7):1361-73
pubmed: 17190600
EMBO J. 2010 Nov 3;29(21):3723-32
pubmed: 20871591
Cell. 2006 Mar 10;124(5):943-55
pubmed: 16530042
J Biol Chem. 2011 Jun 3;286(22):19229-36
pubmed: 21502314
Proteomics. 2004 Jun;4(6):1551-61
pubmed: 15174125
Mol Cell. 2015 Mar 19;57(6):1133-1141
pubmed: 25794620
Cancer Lett. 2015 Jan 28;356(2 Pt B):454-61
pubmed: 25304378
Nat Cell Biol. 2010 Feb;12(2):177-84
pubmed: 20081839
EMBO J. 2011 Sep 23;30(24):4897-907
pubmed: 21946560
Nature. 2003 Feb 27;421(6926):957-61
pubmed: 12607004
Adv Exp Med Biol. 2017;1042:135-162
pubmed: 29357057
Nat Chem Biol. 2015 Oct;11(10):807-14
pubmed: 26344695
Nucleic Acids Res. 2013 Dec;41(22):10334-44
pubmed: 24038466
Cell Cycle. 2011 Aug 1;10(15):2461-70
pubmed: 21734457
Mol Cell. 2009 Jun 26;34(6):735-45
pubmed: 19446481
Structure. 2013 Aug 6;21(8):1450-9
pubmed: 23891287
Cell Cycle. 2014;13(16):2509-16
pubmed: 25486192
Genes Dev. 2007 Jun 15;21(12):1472-7
pubmed: 17575048
Mol Cell Biol. 2014 Jun;34(11):2062-74
pubmed: 24687851
Elife. 2018 Oct 08;7:
pubmed: 30295604
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
J Biol Chem. 2007 Sep 21;282(38):28036-44
pubmed: 17636252
Mol Cell. 2017 Feb 16;65(4):671-684.e5
pubmed: 28132842
Mol Cell Biol. 2014 Apr;34(8):1380-8
pubmed: 24469398
Mol Cell. 2019 May 2;74(3):571-583.e8
pubmed: 30898438
Nat Commun. 2015 Mar 12;6:6572
pubmed: 25762097
Trends Cell Biol. 2014 Feb;24(2):108-17
pubmed: 24094932
Genes Dev. 1997 Dec 15;11(24):3387-400
pubmed: 9407031
Science. 2011 Jun 10;332(6035):1313-7
pubmed: 21659603
Nucleic Acids Res. 2011 Jan;39(1):313-24
pubmed: 20724438
Mol Cell. 2013 Sep 26;51(6):723-736
pubmed: 24074952
Genes Dev. 2006 Jun 15;20(12):1583-96
pubmed: 16778077
DNA Repair (Amst). 2014 Jul;19:169-75
pubmed: 24746645
Structure. 2017 Oct 3;25(10):1582-1588.e3
pubmed: 28919440
Cell Res. 2015 Jan;25(1):9-23
pubmed: 25403473
EMBO J. 2010 Feb 3;29(3):574-85
pubmed: 20010693
Cell Rep. 2017 Jul 11;20(2):297-307
pubmed: 28700933
Cell Rep. 2015 Dec 15;13(10):2081-9
pubmed: 26628370
Genome Biol. 2006;7(10):R100
pubmed: 17076895
J Biol Chem. 2005 Jan 14;280(2):1186-92
pubmed: 15533933
Mol Cell Biol. 2006 Aug;26(16):6056-64
pubmed: 16880517

Auteurs

Nicolas Bigot (N)

Cancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom.

Matthew Day (M)

Cancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom.

Robert A Baldock (RA)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom.

Felicity Z Watts (FZ)

Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom.

Antony W Oliver (AW)

Cancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom.

Laurence H Pearl (LH)

Cancer Research UK DNA Repair Enzymes Group, Genome Damage and Stability Centre, School of Life Sciences, University of Sussex, Brighton, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH